Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5820
Gene Symbol: PVT1
PVT1
0.010 Biomarker disease BEFREE Silencing of lncRNA PVT1 by miR-214 inhibits the oncogenic GDF15 signaling and suppresses hepatocarcinogenesis. 31677796 2020
Entrez Id: 5029
Gene Symbol: P2RY2
P2RY2
0.010 Biomarker disease BEFREE Therefore, our aim was to dissect the functions of extracellular ATP and P2Y2 receptors (P2Y2R) during hepatocarcinogenesis. 31822494 2020
Entrez Id: 406885
Gene Symbol: MIRLET7C
MIRLET7C
0.010 Biomarker disease BEFREE In this study, we aimed to investigate the relationship between HoxB7 and let-7c in liver carcinogenesis. 31609764 2020
Entrez Id: 3217
Gene Symbol: HOXB7
HOXB7
0.010 Biomarker disease BEFREE In this study, we aimed to investigate the relationship between HoxB7 and let-7c in liver carcinogenesis. 31609764 2020
Entrez Id: 7042
Gene Symbol: TGFB2
TGFB2
0.010 AlteredExpression disease BEFREE In vivo, restoration of TGFβ2 expression blocked Bmi1/Ras-driven hepatocarcinogenesis in mice. 31591477 2020
Entrez Id: 7189
Gene Symbol: TRAF6
TRAF6
0.010 Biomarker disease BEFREE Conclusion: These findings demonstrate the oncogenic potential of TRAF6 during hepatocarcinogenesis by modulating TRAF6/HDAC3/c-Myc signaling, with potential implications for HCC therapy. 31155734 2020
Entrez Id: 6721
Gene Symbol: SREBF2
SREBF2
0.010 Biomarker disease BEFREE Blocking cholesterol synthesis via the dominant negative form of Srebp2 (<i>dnSrebp2</i>) completely prevented sgPten/c-Met-driven hepatocarcinogenesis in <i>Fasn</i> knockout mice. 30954949 2020
Entrez Id: 342132
Gene Symbol: ZNF774
ZNF774
0.010 Biomarker disease BEFREE Together, these results uncover a key role for the ZNF774/NuRD-NOTCH2 axis in hepatocarcinogenesis. 31659254 2020
Entrez Id: 23677
Gene Symbol: SH3BP4
SH3BP4
0.010 Biomarker disease BEFREE The aim of this study was to elucidate the role of TTP in hepatocarcinogenesis and HCC progression. 31717307 2019
Entrez Id: 139341
Gene Symbol: FUNDC1
FUNDC1
0.010 Biomarker disease BEFREE FUN14 Domain-Containing 1-Mediated Mitophagy Suppresses Hepatocarcinogenesis by Inhibition of Inflammasome Activation in Mice. 30053328 2019
Entrez Id: 8842
Gene Symbol: PROM1
PROM1
0.010 AlteredExpression disease BEFREE PTEN plays a key role in hepatocarcinogenesis and reduction of PTEN expression is related to increased expression of CD133, EpCAM and CK19, which is a useful tool to evaluate HCC prognosis and recurrence. 31126975 2019
Entrez Id: 84978
Gene Symbol: FRMD5
FRMD5
0.010 Biomarker disease BEFREE C-terminal truncated HBx protein activates caveolin-1/LRP6/β-catenin/FRMD5 axis in promoting hepatocarcinogenesis. 30583072 2019
Entrez Id: 3791
Gene Symbol: KDR
KDR
0.010 AlteredExpression disease BEFREE Increased expression of Vegfa and Vegfr2 was observed during promotion phase of hepatocarcinogenesis, which was not reversed by TB treatment. 30590392 2019
Entrez Id: 7086
Gene Symbol: TKT
TKT
0.010 Biomarker disease BEFREE Furthermore, DEN and high-fat diet (HFD)-induced liver carcinogenesis was reduced in <i>TKT<sup>flox/flox</sup>Alb-Cre</i> mice compared with control littermates. 31101762 2019
Entrez Id: 50506
Gene Symbol: DUOX2
DUOX2
0.010 Biomarker disease BEFREE Although there are associations among oxidative stress, reduced nicotinamide adenine dinucleotide phosphate oxidase (NOX) activation, and hepatocellular carcinoma (HCC) development, it is not clear how NOX contributes to hepatocarcinogenesis. 30445007 2019
Entrez Id: 10569
Gene Symbol: SLU7
SLU7
0.010 Biomarker disease BEFREE Therefore, the dowregulation of SLU7 and the alterations of this pathway that we observe in the cirrhotic liver could be involved in the process of hepatocarcinogenesis. 30657957 2019
Entrez Id: 7098
Gene Symbol: TLR3
TLR3
0.010 AlteredExpression disease BEFREE Lastly, in the transgenic mouse model of HCC, absence of TLR3 expression was accompanied by a lower rate of preneoplastic hepatocyte apoptosis and accelerated hepatocarcinogenesis without altering the tumor immune infiltrate. 31220470 2019
Entrez Id: 6615
Gene Symbol: SNAI1
SNAI1
0.010 Biomarker disease BEFREE Here, we analyzed the functional relevance of SNAI1 in promoting hepatocarcinogenesis in the context of the AKT/c-Met-driven mouse liver tumor model (AKT/c-Met/SNAI1). 31383647 2019
Entrez Id: 10365
Gene Symbol: KLF2
KLF2
0.010 Biomarker disease BEFREE Krüppel-like factor 2 inhibits hepatocarcinogenesis through negative regulation of the Hedgehog pathway. 30719823 2019
Entrez Id: 79019
Gene Symbol: CENPM
CENPM
0.010 AlteredExpression disease BEFREE Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms. 31703591 2019
Entrez Id: 10549
Gene Symbol: PRDX4
PRDX4
0.010 Biomarker disease BEFREE In this study, for hepatocarcinogenesis, wild-type (WT), PRDX4 knockout (PRDX4<sup>-/y</sup>), and human PRDX4 transgenic (hPRDX4<sup>+/+</sup>) mice were given a weekly intraperitoneal injection of diethylnitrosamine for 25 weeks. 29687726 2019
Entrez Id: 3320
Gene Symbol: HSP90AA1
HSP90AA1
0.010 AlteredExpression disease BEFREE Indeed, HSP90 is highly expressed in different tumor types, but its role in hepatocarcinogenesis remains unclear. 30488605 2019
Entrez Id: 10663
Gene Symbol: CXCR6
CXCR6
0.010 Biomarker disease BEFREE We assessed the roles of CXCR6-dependent immune mechanisms in hepatocarcinogenesis. 30710528 2019
Entrez Id: 38
Gene Symbol: ACAT1
ACAT1
0.010 Biomarker disease BEFREE Decades of study have utilized the <i>Mat1a</i>-knockout (KO) mouse that spontaneously develops non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) to elucidate a variety of mechanisms by which MAT proteins dysregulation contributes to liver carcinogenesis. 31496615 2019
Entrez Id: 7350
Gene Symbol: UCP1
UCP1
0.010 AlteredExpression disease BEFREE However, it remains unknown whether HBx modulates the enzyme activity of UCP and thereby influences hepatocarcinogenesis. 30903204 2019